Key result
An ensemble model using serial cytokine measurements significantly improved 1-year mortality prediction in heart failure compared to baseline data alone (C-statistic 0.84 vs 0.74; P=0.04).
Why the study?
Do predictive models incorporating time-series measurements of cytokines improve 1-year mortality prediction in heart failure patients compared to baseline clinical models?
Cohort (n=963)
Do predictive models incorporating time-series measurements of cytokines improve 1-year mortality prediction in heart failure patients compared to baseline clinical models?
Effect estimate: C-statistic 0.84
Absolute Event Rate: 0.84% vs 0.74%
p-value: p=0.04
Incorporating serial measurements of biomarkers like cytokines into ensemble models significantly improves the accuracy of 1-year mortality prediction in patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Serial cytokines may refine HF mortality prediction; hypothesis-generating and requires prospective validation before practice change.
Subramanian et al. (2011) conducted a cohort in chronic heart failure (n=963). Serial measurements of cytokines and their receptors vs. Baseline clinical variables and baseline cytokine levels was evaluated on 1-year mortality prediction accuracy (C-statistic) (C-statistic 0.84, p=0.04). An ensemble model using serial cytokine measurements significantly improved 1-year mortality prediction in heart failure compared to baseline data alone (C-statistic 0.84 vs 0.74; P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: